Evidence map›Paper›PMID 33790567›Full record

ArticleVascular health and risk management2021

Early Detection of Negative Smoking Impacts: Vascular Adaptation Deviation Based on Quantification of Circulated Endothelial Activation Markers.

Kumboyono Kumboyono, Wiwit Nurwidyaningtyas, Indah Nur Chomsy, Titin Andri Wihastuti

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Vascular health and risk management, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07316400 (Protocol for a Randomized, Single-Blind, Controlled Clinical Trial Evaluating the Effect of Peptide Polysaccharide Supplementation on Serum Malondialdehyde, Interleukin-6, and Cotinine Levels), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07316400 nacompletednot on this mapstarted 2024, after this paper: background citation

Protocol for a Randomized, Single-Blind, Controlled Clinical Trial Evaluating the Effect of Peptide Polysaccharide Supplementation on Serum Malondialdehyde, Interleukin-6, and Cotinine Levels

TypeinterventionalSponsorUniversity of BrawijayaRan2024 to 2024Enrolled200ConditionsOxidative Stress, Inflammation, Cigarette SmokingArmsPsP
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kumboyono KumboyonoNursing Department, Faculty of Medicine, University of Brawijaya, Malang, 65145, Indonesia.ORCID 0000-0003-2124-8673
Wiwit NurwidyaningtyasDoctoral Program of Medical Science, Faculty of Medicine, University of Brawijaya, Malang, 65145, Indonesia.ORCID 0000-0003-4472-4388
Indah Nur ChomsyDoctoral Program of Medical Science, Faculty of Medicine, University of Brawijaya, Malang, 65145, Indonesia.ORCID 0000-0002-1050-3571
Titin Andri WihastutiDepartment of Biomedicine, Faculty of Medicine, University of Brawijaya, Malang, 65145, Indonesia.ORCID 0000-0001-6476-0541
University of Brawijaya · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSmoking can cause vascular damage in the form of an inflammatory reaction characterized by endothelial activation. Endothelial activation forms a pathological adaptation pattern so that it can induce the atherogenesis process. Several markers, such as E-selectin, platelet-derived micro particles (PMPs) and hematopoietic stem cell (HSC) can identify the activation of endothelial in circulating blood. Therefore, the deviation of vascular adaptation due to smoking can be detected early through the feedback mechanism between E-selectin, PMPs, and HSC. PURPOSE: This study aims to analyze the initial picture of the negative impact of smoking on vascular adaptation by measuring E-selectin, PMPs, and HSC in the peripheral blood circulation. Participant criteria and methods: Peripheral blood samples (5 mL) were taken from each participant, both the smoking group (n = 30) and the non-smoker group (n = 31) to obtain peripheral blood mononuclear cells (PBMNC). PBMNC was isolated using ficoll-based gradient centrifugation. The flow cytometry assay method used to measure the E-selectin, PMPs and hematopoietic stem cells.

resultsThe mean of circulating E-selectin in smokers was higher than that of non-smokers. On the other hand, the average number of PMPs and HSCs in smokers was lower than non-smokers.

conclusionSmoking increases the risk of accelerated vascular block formation, as indicated by an increase in the amount of circulating E-selectin. The increase in E-selectin in the blood vessels mediates the increased adhesion of PMPs in the vascular area so that the number of circulating PMPs in smokers decreases. The decrease in circulating PMPs decreases the signal of vascular repair, which is characterized by a decline in the number of HSCs.

Indexed as

SmokersAdultBiomarkersBlood PlateletsCardiovascular DiseasesCase-Control StudiesCell-Derived MicroparticlesCross-Sectional StudiesEarly DiagnosisEndothelial CellsE-SelectinHematopoietic Stem CellsHumansNon-SmokersPredictive Value of TestsSmokingBiomarkersE-SelectinSELE protein, humanatherosclerosiscardiovascular diseaseendothelial injuryperipheral blood mononuclear cellssmoker

Identifiers

PMID33790567
PMCPMC8001718
OpenAlexW3136781773

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.